<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Stewjuriya - Latest News</title>
<link href="https://news.prfree.org/rss/stewjuriya/latest.xml"></link>
<updated>2026-07-21T21:50:55+00:00</updated>
<id>urn:uuid:3990259b-7e2d-4efc-aafb-d7728645b70e</id>
<entry>
<title>In addition they narrowed their focus to boosting</title>
<link href="https://news.prfree.org/@stewjuriya/in-addition-they-narrowed-their-focus-to-boosting-3rm6ea8xxkeq"></link>
<id>urn:uuid:1d96ce41-7371-bfc8-26cb-d512ef12374f</id>
<summary type="html"><![CDATA[prior, APE specializes in ‘substance over hype,’ but with slash than expected dosage levels, it begs the]]></summary>
<updated>2016-07-27T05:53:47+00:00</updated>
</entry>
</feed>